Trials / Completed
CompletedNCT00695565
Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy
A Multicenter, Randomized, Double-Blind, Parallel-Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% With Placebo in the Management of Pain Associated With Painful Diabetic Neuropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (actual)
- Sponsor
- Arcion Therapeutics Inc · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether ARC-4558 is effective in managing pain associated with painful diabetic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo Gel | TID x 12 weeks |
| DRUG | Clonidine Topical Gel (ARC-4558) | TID x 12 weeks |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-12-01
- Completion
- 2010-02-01
- First posted
- 2008-06-12
- Last updated
- 2016-11-08
- Results posted
- 2016-11-08
Locations
16 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00695565. Inclusion in this directory is not an endorsement.